Interleukin-18 null mutation increases weight and food intake and reduces energy expenditure and lipid substrate utilization in high-fat diet fed mice

Brain, Behavior, and Immunity

Volumn 37, Issue , 2014, Pages 45-53

  Zorrilla, Eric P ^a   Conti, Bruno ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Body weight; Cosinor analysis or circadian rhythm; Energy expenditure or metabolism; Food intake or appetite; High fat diet; Indirect calorimetry; Interleukin 18; Locomotor or physical activity; Obesity or overweight; Proinflammatory cytokine

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; LIPID; RECOMBINANT INTERLEUKIN 18;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL METABOLIC RATE; BODY WEIGHT; CIRCADIAN RHYTHM; CONTROLLED STUDY; ENERGY EXPENDITURE; ENERGY METABOLISM; FEMALE; FOOD INTAKE; GENE MUTATION; LIPID DIET; LIPID METABOLISM; LOW FAT DIET; MOTOR ACTIVITY; MOUSE; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL;

BODY WEIGHT; COSINOR ANALYSIS OR CIRCADIAN RHYTHM; ENERGY EXPENDITURE OR METABOLISM; FOOD INTAKE OR APPETITE; HIGH-FAT DIET; INDIRECT CALORIMETRY; INTERLEUKIN-18; LOCOMOTOR OR PHYSICAL ACTIVITY; OBESITY OR OVERWEIGHT; PROINFLAMMATORY CYTOKINE;

ANIMALS; DIET, HIGH-FAT; EATING; ENERGY METABOLISM; FEMALE; INTERLEUKIN-18; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; MUTATION; RECEPTORS, INTERLEUKIN-18; WEIGHT GAIN;

EID: 84896711732     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.12.001     Document Type: Article

References (73)

1. Alboni S., Cervia D., Ross B., Montanari C., Gonzalez A.S., Sanchez-Alavez M., Marcondes M.C., De Vries D., Sugama S., Brunello N., Blom J., Tascedda F., Conti B. Mapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain. J. Neuroimmunol. 2009, 214:43-54.
2. Alboni S., Cervia D., Sugama S., Conti B. Interleukin 18 in the CNS. J. Neuroinflammation 2010, 7:9.
3. Alboni S., Montanari C., Benatti C., Blom J.M., Simone M.L., Brunello N., Caggia F., Guidotti G., Marcondes M.C., Sanchez-Alavez M., Conti B., Tascedda F. Constitutive and LPS-regulated expression of interleukin-18 receptor beta variants in the mouse brain. Brain Behav. Immun. 2011, 25:483-493.
4. Amat P., Pastor F.E., Blazquez J.L., Pelaez B., Sanchez A., Alvarez-Morujo A.J., Toranzo D., Amat-Peral G. Lateral evaginations from the third ventricle into the rat mediobasal hypothalamus: an amplification of the ventricular route. Neuroscience 1999, 88:673-677.
5. Arch J.R., Hislop D., Wang S.J., Speakman J.R. Some mathematical and technical issues in the measurement and interpretation of open-circuit indirect calorimetry in small animals. Int. J. Obes. (Lond.) 2006, 30:1322-1331.
6. Arsenijevic D., Garcia I., Vesin C., Vesin D., Arsenijevic Y., Seydoux J., Girardier L., Ryffel B., Dulloo A., Richard D. Differential roles of tumor necrosis factor-alpha and interferon-gamma in mouse hypermetabolic and anorectic responses induced by LPS. Eur. Cytokine Netw. 2000, 11:662-668.
7. Bandini L.G., Schoeller D.A., Dietz W.H. Metabolic differences in response to a high-fat vs. a high-carbohydrate diet. Obes. Res. 1994, 2:348-354.
8. Barrachina M.D., Martinez V., Wang L., Wei J.Y., Tache Y. Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. Proc. Natl. Acad. Sci. USA 1997, 94:10455-10460.
9. Berger R.J., Phillips N.H. Comparative aspects of energy metabolism, body temperature and sleep. Acta Physiol. Scand. Suppl. 1988, 574:21-27.
10. Born T.L., Morrison L.A., Esteban D.J., VandenBos T., Thebeau L.G., Chen N., Spriggs M.K., Sims J.E., Buller R.M. A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response. J. Immunol. 2000, 164:3246-3254.
11. Bruun J.M., Stallknecht B., Helge J.W., Richelsen B. Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss. Eur. J. Endocrinol. 2007, 157:465-471.
12. Chen A., Zorrilla E., Smith S., Rousso D., Levy C., Vaughan J., Donaldson C., Roberts A., Lee K.F., Vale W. Urocortin 2-deficient mice exhibit gender-specific alterations in circadian hypothalamus-pituitary-adrenal axis and depressive-like behavior. J. Neurosci. 2006, 26:5500-5510.
13. Cheunsuang O., Stewart A.L., Morris R. Differential uptake of molecules from the circulation and CSF reveals regional and cellular specialisation in CNS detection of homeostatic signals. Cell Tissue Res. 2006, 325:397-402.
14. Conti B., Jahng J.W., Tinti C., Son J.H., Joh T.H. Induction of interferon-gamma inducing factor in the adrenal cortex. J. Biol. Chem. 1997, 272:2035-2037.
15. Conti B., Park L.C., Calingasan N.Y., Kim Y., Kim H., Bae Y., Gibson G.E., Joh T.H. Cultures of astrocytes and microglia express interleukin 18. Brain Res. Mol. Brain Res. 1999, 67:46-52.
16. Culhane A.C., Hall M.D., Rothwell N.J., Luheshi G.N. Cloning of rat brain interleukin-18 cDNA. Mol. Psychiatry 1998, 3:362-366.
17. Cumiskey D., Pickering M., O'Connor J.J. Interleukin-18 mediated inhibition of LTP in the rat dentate gyrus is attenuated in the presence of mGluR antagonists. Neurosci. Lett. 2007, 412:206-210.
18. Curran B., O'Connor J.J. The pro-inflammatory cytokine interleukin-18 impairs long-term potentiation and NMDA receptor-mediated transmission in the rat hippocampus in vitro. Neuroscience 2001, 108:83-90.
19. de Metz J., Sprangers F., Endert E., Ackermans M.T., ten Berge I.J., Sauerwein H.P., Romijn J.A. Interferon-gamma has immunomodulatory effects with minor endocrine and metabolic effects in humans. J. Appl. Physiol. 1999, 86:517-522.
20. Ebbeling C.B., Swain J.F., Feldman H.A., Wong W.W., Hachey D.L., Garcia-Lago E., Ludwig D.S. Effects of dietary composition on energy expenditure during weight-loss maintenance. JAMA 2012, 307:2627-2634.
21. Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., Quagliaro L., Ceriello A., Giugliano D. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002, 106:2067-2072.
22. Esposito K., Pontillo A., Ciotola M., Di Palo C., Grella E., Nicoletti G., Giugliano D. Weight loss reduces interleukin-18 levels in obese women. J. Clin. Endocrinol. Metab. 2002, 87:3864-3866.
23. Esposito K., Pontillo A., Di Palo C., Giugliano G., Masella M., Marfella R., Giugliano D. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003, 289:1799-1804.
24. Evans J., Collins M., Jennings C., van der Merwe L., Soderstrom I., Olsson T., Levitt N.S., Lambert E.V., Goedecke J.H. The association of interleukin-18 genotype and serum levels with metabolic risk factors for cardiovascular disease. Eur. J. Endocrinol. 2007, 157:633-640.
25. Even P.C., Nadkarni N.A. Indirect calorimetry in laboratory mice and rats: principles, practical considerations, interpretation and perspectives. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012, 303:R459-R476.
26. Fain J.N. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam. Horm. 2006, 74:443-477.
27. Garcia M.C., Wernstedt I., Berndtsson A., Enge M., Bell M., Hultgren O., Horn M., Ahren B., Enerback S., Ohlsson C., Wallenius V., Jansson J.O. Mature-onset obesity in interleukin-1 receptor I knockout mice. Diabetes 2006, 55:1205-1213.
28. Gatti S., Beck J., Fantuzzi G., Bartfai T., Dinarello C.A. Effect of interleukin-18 on mouse core body temperature. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 282:R702-R709.
29. Gordon R.R., Hunter K.W., Sorensen P., Pomp D. Genotype X diet interactions in mice predisposed to mammary cancer. I. Body weight Fat Mamm. Genome 2008, 19:163-178.
30. Hung J., McQuillan B.M., Chapman C.M., Thompson P.L., Beilby J.P. Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler Thromb Vasc. Biol. 2005, 25:1268-1273.
31. Kanno T., Nagata T., Yamamoto S., Okamura H., Nishizaki T. Interleukin-18 stimulates synaptically released glutamate and enhances postsynaptic AMPA receptor responses in the CA1 region of mouse hippocampal slices. Brain Res. 2004, 1012:190-193.
32. Kleiber M. The fire of life: an introduction to animal energetics 1975, Krieger Publishing Company, New York.
33. Klockener T., Hess S., Belgardt B.F., Paeger L., Verhagen L.A., Husch A., Sohn J.W., Hampel B., Dhillon H., Zigman J.M., Lowell B.B., Williams K.W., Elmquist J.K., Horvath T.L., Kloppenburg P., Bruning J.C. High-fat feeding promotes obesity via insulin receptor/PI3K-dependent inhibition of SF-1 VMH neurons. Nat. Neurosci. 2011, 14:911-918.
34. Koch W., Wolferstetter H., Schatke A., Schomig A., Kastrati A. Interleukin 18 gene variation and risk of acute myocardial infarction. Cytokine 2011.
35. Kusudo T., Wang Z., Mizuno A., Suzuki M., Yamashita H. TRPV4 deficiency increases skeletal muscle metabolic capacity and resistance against diet-induced obesity. J. Appl. Physiol. 2012, 112:1223-1232.
36. Lee M., Kim A., Chua S.C., Obici S., Wardlaw S.L. Transgenic MSH overexpression attenuates the metabolic effects of a high-fat diet. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E121-E131.
37. Leick L., Lindegaard B., Stensvold D., Plomgaard P., Saltin B., Pilegaard H. Adipose tissue interleukin-18 mRNA and plasma interleukin-18: effect of obesity and exercise. Obesity (Silver Spring) 2007, 15:356-363.
38. Madsen E.L., Bruun J.M., Skogstrand K., Hougaard D.M., Christiansen T., Richelsen B. Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects. Metabolism 2009, 58:946-953.
39. McNeill G., Bruce A.C., Ralph A., James W.P. Inter-individual differences in fasting nutrient oxidation and the influence of diet composition. Int. J. Obes. 1988, 12:455-463.
40. Melen E., Himes B.E., Brehm J.M., Boutaoui N., Klanderman B.J., Sylvia J.S., Lasky-Su J. Analyses of shared genetic factors between asthma and obesity in children. J. Allergy Clin. Immunol. 2010, 126(631-637):e631-e638.
41. Membrez M., Ammon-Zufferey C., Philippe D., Aprikian O., Monnard I., Mace K., Darimont C. Interleukin-18 protein level is upregulated in adipose tissue of obese mice. Obesity (Silver Spring) 2009, 17:393-395.
42. Mounien L., Do Rego J.C., Bizet P., Boutelet I., Gourcerol G., Fournier A., Brabet P., Costentin J., Vaudry H., Jegou S. Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system. Neuropsychopharmacology 2009, 34:424-435.
43. Netea M.G., Joosten L.A., Lewis E., Jensen D.R., Voshol P.J., Kullberg B.J., Tack C.J., van Krieken H., Kim S.H., Stalenhoef A.F., van de Loo F.A., Verschueren I., Pulawa L., Akira S., Eckel R.H., Dinarello C.A., van den Berg W., van der Meer J.W. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat. Med. 2006, 12:650-656.
44. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K., et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995, 378:88-91.
45. Opp M.R., Toth L.A. Circadian modulation of interleukin-1-induced fever in intact and vagotomized rats. Ann. N. Y. Acad. Sci. 1997, 813:435-436.
46. Paula G.S., Souza L.L., Cabanelas A., Bloise F.F., Mello-Coelho V., Wada E., Ortiga-Carvalho T.M., Oliveira K.J., Pazos-Moura C.C. Female mice target deleted for the neuromedin B receptor have partial resistance to diet-induced obesity. J. Physiol. 2010, 588:1635-1645.
47. Penttila I.A., Flesch I.E., McCue A.L., Powell B.C., Zhou F.H., Read L.C., Zola H. Maternal milk regulation of cell infiltration and interleukin 18 in the intestine of suckling rat pups. Gut 2003, 52:1579-1586.
48. Plata-Salaman C.R. Cytokines and feeding. Int. J. Obes. Relat. Metab. Disord. 2001, 25(Suppl 5):S48-S52.
49. Presta I., Andreozzi F., Succurro E., Marini M.A., Laratta E., Lauro R., Hribal M.L., Perticone F., Sesti G. IL-18 gene polymorphism and metabolic syndrome. Nutr. Metab. Cardiovasc. Dis. 2009, 19:e5-e6.
50. Rashotte M.E., Basco P.S., Henderson R.P. Daily cycles in body temperature, metabolic rate, and substrate utilization in pigeons: influence of amount and timing of food consumption. Physiol. Behav. 1995, 57:731-746.
51. Rumpler W.V., Seale J.L., Miles C.W., Bodwell C.E. Energy-intake restriction and diet-composition effects on energy expenditure in men. Am. J. Clin. Nutr. 1991, 53:430-436.
52. Semjonous N.M., Smith K.L., Parkinson J.R., Gunner D.J., Liu Y.L., Murphy K.G., Ghatei M.A., Bloom S.R., Small C.J. Coordinated changes in energy intake and expenditure following hypothalamic administration of neuropeptides involved in energy balance. Int. J. Obes. (Lond.) 2009, 33:775-785.
53. Skurk T., Kolb H., Muller-Scholze S., Rohrig K., Hauner H., Herder C. The proatherogenic cytokine interleukin-18 is secreted by human adipocytes. Eur. J. Endocrinol. 2005, 152:863-868.
54. Strader A.D., Reizes O., Woods S.C., Benoit S.C., Seeley R.J. Mice lacking the syndecan-3 gene are resistant to diet-induced obesity. J. Clin. Invest. 2004, 114:1354-1360.
55. Sugama S., Cho B.P., Baker H., Joh T.H., Lucero J., Conti B. Neurons of the superior nucleus of the medial habenula and ependymal cells express IL-18 in rat CNS. Brain Res. 2002, 958:1-9.
56. Sugama S., Kim Y., Baker H., Tinti C., Kim H., Joh T.H., Conti B. Tissue-specific expression of rat IL-18 gene and response to adrenocorticotropic hormone treatment. J. Immunol. 2000, 165:6287-6292.
57. Sun J., Xu Y., Dai Z., Sun Y. Intermittent high glucose stimulate MCP-l, IL-18, and PAI-1, but inhibit adiponectin expression and secretion in adipocytes dependent of ROS. Cell Biochem. Biophys. 2009, 55:173-180.
58. Sun L., Hu F.B., Yu Z., Li H., Liu H., Wang X., Yu D., Wu H., Zhang G., Zong G., Liu Y., Lin X. Lean body mass, interleukin 18, and metabolic syndrome in apparently healthy Chinese. PLoS ONE 2011, 6:e18104.
59. Sutton G.M., Trevaskis J.L., Hulver M.W., McMillan R.P., Markward N.J., Babin M.J., Meyer E.A., Butler A.A. Diet-genotype interactions in the development of the obese, insulin-resistant phenotype of C57BL/6J mice lacking melanocortin-3 or -4 receptors. Endocrinology 2006, 147:2183-2196.
60. Takeda K., Tsutsui H., Yoshimoto T., Adachi O., Yoshida N., Kishimoto T., Okamura H., Nakanishi K., Akira S. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 1998, 8:383-390.
61. Torigoe K., Ushio S., Okura T., Kobayashi S., Taniai M., Kunikata T., Murakami T., Sanou O., Kojima H., Fujii M., Ohta T., Ikeda M., Ikegami H., Kurimoto M. Purification and characterization of the human interleukin-18 receptor. J. Biol. Chem. 1997, 272:25737-25742.
62. Verboeket-van de Venne W.P., Westerterp K.R., ten Hoor F. Substrate utilization in man: effects of dietary fat and carbohydrate. Metabolism 1994, 43:152-156.
63. Vilarrasa N., Vendrell J., Sanchez-Santos R., Broch M., Megia A., Masdevall C., Gomez N., Soler J., Pujol J., Bettonica C., Aranda H., Gomez J.M. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients. Clin. Endocrinol. (Oxf) 2007, 67:679-686.
64. Wallenius V., Wallenius K., Ahren B., Rudling M., Carlsten H., Dickson S.L., Ohlsson C., Jansson J.O. Interleukin-6-deficient mice develop mature-onset obesity. Nat. Med. 2002, 8:75-79.
65. Wang N., Sugama S., Conti B., Teramoto A., Shibasaki T. Interleukin-18 mRNA expression in the rat pituitary gland. J. Neuroimmunol. 2006, 173:117-125.
66. Weiss T.W., Arnesen H., Troseid M., Kaun C., Hjerkinn E.M., Huber K., Wojta J., Seljeflot I. Adipose tissue expression of interleukin-18 mRNA is elevated in subjects with metabolic syndrome and independently associated with fasting glucose. Wien Klin Wochenschr 2011.
67. Wheeler R.D., Culhane A.C., Hall M.D., Pickering-Brown S., Rothwell N.J., Luheshi G.N. Detection of the interleukin 18 family in rat brain by RT-PCR. Brain Res. Mol. Brain Res. 2000, 77:290-293.
68. Wong S., Pinkney J. Role of cytokines in regulating feeding behaviour. Curr Drug Targets 2004, 5:251-263.
69. Wortley K.E., Anderson K.D., Garcia K., Murray J.D., Malinova L., Liu R., Moncrieffe M., Thabet K., Cox H.J., Yancopoulos G.D., Wiegand S.J., Sleeman M.W. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc. Natl. Acad. Sci. USA 2004, 101:8227-8232.
70. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
71. Zigman J.M., Nakano Y., Coppari R., Balthasar N., Marcus J.N., Lee C.E., Jones J.E., Deysher A.E., Waxman A.R., White R.D., Williams T.D., Lachey J.L., Seeley R.J., Lowell B.B., Elmquist J.K. Mice lacking ghrelin receptors resist the development of diet-induced obesity. J. Clin. Invest. 2005, 115:3564-3572.
72. Zilverschoon G.R., Tack C.J., Joosten L.A., Kullberg B.J., van der Meer J.W., Netea M.G. Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus. Int. J. Obes. (Lond.) 2008, 32:1407-1414.
73. Zorrilla E.P., Sanchez-Alavez M., Sugama S., Brennan M., Fernandez R., Bartfai T., Conti B. Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency. Proc. Natl. Acad. Sci. USA 2007, 104:11097-11102.